Outer membrane protein of Neisseria meningitidis as a mucosal adjuvant for lipopolysaccharide of Brucella melitensis in mouse and guinea pig intranasal immunization models

Infection and Immunity

Volumn 64, Issue 12, 1996, Pages 5263-5268

  Van de Verg, Lillian L ^a   Hartman, Antoinette B ^a   Bhattacharjee, Apurba K ^a   Tall, Ben D ^b   Yuan, Liang ^a,d   Sasala, Kris ^a,e   Hadfield, Ted L ^c   Zollinger, Wendell D ^a   Hoover, David L ^a   Warren, Richard L ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; BACTERIAL VACCINE; BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M; OUTER MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BRUCELLA MELITENSIS; BRUCELLOSIS; CONTROLLED STUDY; GUINEA PIG; IMMUNIZATION; INTRANASAL DRUG ADMINISTRATION; LUNG; LUNG LAVAGE; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

EID: 10544254260     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.12.5263-5268.1996     Document Type: Article

References (28)

1. Alving, C. R. 1995. Liposomal vaccines: clinical status and immunological presentation for humoral and cellular immunity. Ann. N.Y. Acad. Sci. 754: 143-152.
2. Baldwin, C. L., and A. J. Winter. 1994. Macrophages and Brucella. Immunol. Ser. 60:363-380.
3. Baqar, S., L. A. Applebee, and A. L. Bourgeois. 1945. Immunogenicity and protective efficacy of a prototype Campylobacter killed whole-cell vaccine in mice. Infect. Immun. 63:3731-3735.
4. Bhattacharjee, A. K., S. W. Opal, R. Taylor, R. Niso, M. Semenuk, W. D. Zollinger, E. E. Moran, L. Young, C. Hammack, J. C. Sadoff, and A. S. Cross. A non-covalent complex vaccine prepared with detoxified Escherichia culi J5 (Rc chemotype) lipopolysaccharidc and Neisseria meningitidis group B outer membrane protein produces protective antibodies against gram-negative hacteremia. J. Infect. Dis., in press.
5. Bundle, D. R., J. W. Cherwonogrodzky, M. Caroff, and M. B. Perry. 1987. The lipopolysaccharides of Brucella abortus and B. melilensis. Ann. Inst. Pasteur Microbiol. 138:92-98.
6. Bundle, D. R., J. W. Cherwonogrodzky, and M. Perry. 1987. Structural elucidation of the Brucella melitensis M antigen by high resolution NMR at 500 Mhz. Biochemistry 26:8717-8726.
7. Chen, K.-S., D. B. Burlington, and G. V. Quinnan. 1987. Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragaslrically with inactivated influenza virus vaccine. J. Virol. 61:2150-2154.
8. Cheville, N. F., M. G. Stevens, A. E. Jensen, F. M. Tatum, and S. M. Hailing. 1993. Immune responses and protection against infection and abortion in cattle experimentally vaccinated with strains of Brucella abortus. Am. J. Vet. Res. 54:1591-1597.
9. Cloeckaert, A., I. Jacques, P. de Wergifosse, G. Dubray, and J. N. Limet. 1992. Protection against Brucella melilensis or Brucella abortus I mice with immunoglobulin G (IgG), IgA and IgM monoclonal antibodies specific for a common epitope shared by the Brucella A and M smooth lipopolysaccharides. Infect. Immun. 60:312-315.
10. Czerkinsky, C. C., L. A. Nilsson, H. Nygren, O. Ouchterlony, and A. Tarkowski. 1983. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods 65:109-121.
11. Donnelly. J. J., K. R. Deck, and M. A. Liu. 1990. Immunogenicity of a Huemophitus influenzae polysaccharide-Neisseria meningitidis outer membrane complex conjugate vaccine. J. Immunol. 145:3071-3079.
12. Dubols, M., K. A. Giles, J. K. Hamilton, P. A. Rebers, and F. Smith. 1956. Colorlmetric method for determination of sugars and related substances. Anal. Chem. 28:350-356.
13. Hartman, A. B., L. L. Van De Verg, H.H. Collins, D. B. Tang, N. O. Bendluk, D. N. Taylor, and C. J. Powell. 1994. Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with Shigella vaccines. Infect. Immun. 62:412-420.
14. Liu, M., A. Friedman, A. I. Oliff, J. Tal, D. Martinez, R. R. Deck, J. T. C. Shieh, T. D. Jenkins, J. J. Donelly, and L. A. Hawe. 1992. A vaccine carrier derived from Neisseria meningitidis with mitogenic activity for lymphocytes. Proc. Natl. Acad. Sci. USA 89:4633-4637.
15. Lycke, N., and J. Holmgren. 1986. Strong adjuvant properties of cholera toxin on gut mucosal immune responses 10 orally presented antigens. Immunology 59:301-308.
16. Mackaness, G. B. 1964. The immunological basis of acquired cellular resistance. J. Exp. Med. 120:105-120.
17. Mikolich, D. J., and J. M. Boyle. 1990. Brucella species, p. 1735-1742. In G. L. Mandell, G. Douglas. Jr., and J. E. Bennett (ed.). Principles and practice of infectious diseases. Churchill Livingstone, New York.
18. Oliveira, S. C., and O. A, Splitter. 1995. CD* + type 1 CD44hi CD45 Rhlo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I- and class II-deficient mice. Eur. J. Immunol. 25:2551-2557.
19. Orr, N., G. Robin, D. Cohen, R. Arnon, and G. H. Lowell. 1993. Immuno genicity and efficacy of oral or intranasal Shigellu flexneri 2a and Shigella simnei protcosome-lipopolysuccharide vaccines in animals models. Infect. Immun. 61:2310-2395.
20. Phalipon, A., M. Kaufman. P. Michetti. J. M. Cavallion, M. Huerre, J. P. Kruehenbuhl, and P. J. Sansonetti. 1994. Protection against invasion of the mouse pulmonary epithelium by a monoclonal IgA directed against Shigella flexneri lipopolysaccharide. Ann. N.Y. Acad. Sci. 730:356-358.
21. Smith, P. K., R. I. Krohn, G. T. Herman, A. K. Mallia, F. H. Gartner, M. D. Provenzano. E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. Klenk. 1985. Measurement of protein using bienchoninic acid. Anal. Biochem. 150:76-85.
22. Snapper, C. M., and W. E. Paul. 1987. lnterferon-y and B cell stimulatory factur-1 reciprocally regulate Ig isotype production. Science 236:944-947.
23. Van De Verg, L. L., C. P. Mallett, H. H. Collini, T. Lursen, C. Hammack, and T. L. Hale. 1995. Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri scrotype 2a infection. Infect. Immun. 63:1947-1954.
24. Winter, A. J., J. T. Duncan, C. G. Santisteban, J. T. Douglas, and L. G. Adams. 1989. Capacity of passively administered antibody to prevent establishment of Brucella abortus infection in mice. Infect. Immun. 57:3438-3444.
25. Zhan, Y., and C. Cheers. 1993. Endogenous gamma Interferon mediates resistance to Brucella abortus infection. Infect. Immun. 61:4899-4901.
26. Zollinger, W. D., D. L. Kasper, B. L. Veltri, and M. S. Artenstein. 1972. Isolation and characterization of a native cell wall complex from Neisserta meningitidis. Infect. Immun. 6:835-851.
27. Zollinger, W. D., K. E. Mandrell, J. M. Grifiss, P. Altleri, and S. Berman. 1979. Complex of meningococcal group B polysaccharidc and type 2 outer membrane protein immunogenic in man. J. Clin. Invest. 63:836-848.
28. Young, E. J. 1995. Brucellosis: current epidemiology, diagnosis, and management. Curr. Clin. Top. Infect. Dis. 15:115-128.